Ningfeng Fiona Li, MD, PhD, MSc
Chief Executive Office &
Chief Medical Officer
Specialist in Clinical Oncology, with extensive research experience in tumour biology and carcinogenesis with publications in high impact journals.
Founder of London Nanjing Life Science (China) Ltd and Suzhou NG Biomedicine Ltd and developed several biotech reagent products, disinfectant products and small molecule pharmaceutical products through prototyping, clinical trials and recently marketing.
Gary Bower, BSc
Chief Operating Officer
Specialist in managing Clinical Trials, with over 25 years’ experience managing studies across all phases, primarily in oncology.
Founder of GTE Consultancy Ltd, supporting small biotechnology companies with clinical & pre-clinical development since 2006.
Hilary Birrell, BSc
Head of Clinical Operations
Biochemist and Clinical Trial Specialist with over 30 years’ experience in multiple indications across Phases I-IV of Drug Development. Early career in AstraZeneca followed by 20 years of consultancy experience. Owner/Director of Carnegie Clinical Research Ltd, Clinical Trial Management CRO, since 2010.
Joseph Irwin, BSc, MSc, MRSB, CBiol, FTOPRA, FRSM, FRSS FZS
Chief Regulatory Adviser
Biochemist/ Pharmacologist by training with experience in Clinical Trials, animal models, cell biology and molecular biology techniques. Joseph has 30 years as a regulatory professional in all therapeutic areas, in the EU, US and international markets; formal J&J Director of Regulatory Affairs EU, founder of LRCS Ltd.
Dawn A Adkin, PhD BPharm (Hons)
CMC Adviser
Independent CMC Consultant with over 25 years of experience in the pharmaceutical industry particularly in the formulation and manufacture of small molecules from early to late-stage development.
Founder of DA Squared Pharma Consulting. Former roles include Product Development Associate Director at AstraZeneca and Director at Molecular Profiles.
Austin Smith,
Deputy Chief Medical Officer
Trained and qualified in Medical Oncology and Pharmaceutical Medicine, Austin has a solid background in all aspects of Oncology and Malignant Hematology, along with Regulatory Science experience across Europe, the US and Asia-Pacific regions, acting in senior and executive positions in biopharma companies. Austin is also a member of the Expert Group for Oncology, representing the Faculty of Pharmaceutical Medicine in the UK
Key
Management
We are a pharmaceutical development company
with experienced executives and a shared vision
to improve the standard of cancer care.
Ningfeng Fiona Li, MD, PhD, MSc
Chief Executive Office &
Chief Medical Officer
Specialist in Clinical Oncology, with extensive research experience in tumour biology and carcinogenesis with publications in high impact journals.
Founder of London Nanjing Life Science (China) Ltd and Suzhou NG Biomedicine Ltd and developed several biotech reagent products, disinfectant products and small molecule pharmaceutical products through prototyping, clinical trials and recently marketing.
Gary Bower, BSc
Chief Operating Officer
Specialist in managing Clinical Trials, with over 25 years’ experience managing studies across all phases, primarily in oncology.
Founder of GTE Consultancy Ltd, supporting small biotechnology companies with clinical & pre-clinical development since 2006.
Hilary Birrell, BSc
Head of Clinical Operations
Biochemist and Clinical Trial Specialist with over 30 years’ experience in multiple indications across Phases I-IV of Drug Development. Early career in AstraZeneca followed by 20 years of consultancy experience. Owner/Director of Carnegie Clinical Research Ltd, Clinical Trial Management CRO, since 2010.
Joseph Irwin, BSc, MSc, MRSB, CBiol, FTOPRA, FRSM, FRSS FZS
Chief Regulatory Adviser
Biochemist/ Pharmacologist by training with experience in Clinical Trials, animal models, cell biology and molecular biology techniques. Joseph has 30 years as a regulatory professional in all therapeutic areas, in the EU, US and international markets; formal J&J Director of Regulatory Affairs EU, founder of LRCS Ltd.
Dawn A Adkin, PhD BPharm (Hons)
CMC Adviser
Independent CMC Consultant with over 25 years of experience in the pharmaceutical industry particularly in the formulation and manufacture of small molecules from early to late-stage development.
Founder of DA Squared Pharma Consulting. Former roles include Product Development Associate Director at AstraZeneca and Director at Molecular Profiles.